MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, INMB has $33,358K in assets. $7,980K in debts. $27,734K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
416.88%
Cash Ratio
376.97%
Debt to Asset Ratio
23.92%
Assets Breakdown
    • Cash and cash equivalents
    • Research and development tax cre...
    • Operating lease right of use as...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued lia...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
27,734 33,374
Research and development tax credit receivable
1,704 1,605
Other tax receivable
760 550
Prepaid expenses and other current assets
472 505
Total current assets
30,670 36,034
Equipment, net
878 706
Operating lease right of use asset
1,064 374
Acquired in-process research and development intangible assets
-0
Other assets
746 570
Total assets
33,358 37,684
Accounts payable and accrued liabilities
6,875 7,671
Deferred liabilities
-511
Accounts payable and accrued liabilities related parties-Related Party
25 184
Operating lease, current liabilities
457 220
Total current liabilities
7,357 8,586
Long-term operating lease liabilities
623 231
Total liabilities
7,980 8,817
Common stock, 0.001 par value, 200,000,000 shares authorized, 26,585,258 and 22,280,451 shares issued and outstanding, respectively
27 27
Additional paid-in capital
229,888 226,904
Accumulated other comprehensive loss
-764 -763
Accumulated deficit
-203,773 -197,301
Total stockholders equity
25,378 28,867
Total liabilities and stockholders equity
33,358 37,684
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$472K Other tax receivable$760K Research and developmenttax credit...$1,704K Cash and cashequivalents$27,734K Other assets$746K Operating lease right ofuse asset$1,064K Equipment, net$878K Total current assets$30,670K Total assets$33,358K Total liabilities andstockholders equity$33,358K Total stockholdersequity$25,378K Total liabilities$7,980K Accumulated deficit-$203,773K Accumulated othercomprehensive loss-$764K Additional paid-in capital$229,888K Long-term operating leaseliabilities$623K Total currentliabilities$7,357K Common stock, 0.001 parvalue, 200,000,000...$27K Operating lease, currentliabilities$457K Accounts payable andaccrued liabilities ...$25K Accounts payable andaccrued liabilities$6,875K

Inmune Bio, Inc. (INMB)

Inmune Bio, Inc. (INMB)